RPL3 and colonic neoplasm: The activation and overexpression of RPL3 by the chemotherapeutic drug 5-fluorouracil (5-FU) induces cell apoptosis and regresses cell proliferation in colon cancer, which suggest that the combination of RPL3 and 5-FU could be a novel therapy in colon cancer [41].